Japanese
|
English
|
Sitemap
|
Investor Relations
|
Environmental and Social Report
|
about Eisai
|
Inquiry
Eisai Global Site
Investor Relations
Environmental and Social Report
about Eisai
Potential Suppliers
Inquiry
Company Introduction Video
Annual Report 2010
Environmental and Social Report 2009
News Release
List
July 30, 2010
Continuation of Policy for Protection of the Company's Corporate Value and Common Interests of Shareholders (Shareholder Rights Plan)
July 24, 2010
EISAI ANNOUNCES U.S. FDA APPROVAL FOR NEW HIGHER DOSE ARICEPT® 23 MG TABLET FOR THE TREATMENT OF MODERATE-TO-SEVERE ALZHEIMERS DISEASE
July 20, 2010
FDA ACCEPTS BANZEL® (RUFINAMIDE) ORAL SUSPENSION NDA FOR REVIEW
What's New
List
July 30, 2010
IR “First Quarter Financial Results Explanation for the Fiscal Year Ending March 31, 2011 [Material]”
July 30, 2010
IR “First Quarter Financial Results for the Fiscal Year Ending March 31, 2011”
July 29, 2010
IR “Annual Report 2010”
Information
Notice of shareholder voting results for the 98th ordinary general meeting of shareholders (June 21, 2010)
Notice of resolutions of the 98th ordinary general meeting of shareholders (June 18, 2010)
Corporate Governance Report updated (March 31, 2010)
Privacy Policy
|
Terms of Use
|
Accessibility